416 related articles for article (PubMed ID: 1999178)
1. Cyclosporin-A in vitro decreases bone resorption, osteoclast formation, and the fusion of cells of the monocyte-macrophage lineage.
Orcel P; Denne MA; de Vernejoul MC
Endocrinology; 1991 Mar; 128(3):1638-46. PubMed ID: 1999178
[TBL] [Abstract][Full Text] [Related]
2. Colony stimulating factor-1 plays a role in osteoclast formation and function in bone resorption induced by parathyroid hormone and parathyroid hormone-related protein.
Weir EC; Lowik CW; Paliwal I; Insogna KL
J Bone Miner Res; 1996 Oct; 11(10):1474-81. PubMed ID: 8889847
[TBL] [Abstract][Full Text] [Related]
3. DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones.
Lorenzo JA; Raisz LG; Hock JM
J Clin Invest; 1983 Dec; 72(6):1924-9. PubMed ID: 6643680
[TBL] [Abstract][Full Text] [Related]
4. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
5. Effects of parathyroid hormone and calcitonin on osteoclast formation in vitro.
Feldman RS; Krieger NS; Tashjian AH
Endocrinology; 1980 Oct; 107(4):1137-43. PubMed ID: 7408763
[TBL] [Abstract][Full Text] [Related]
6. Effects of ionizing irradiation on formation and resorbing activity of osteoclasts in vitro.
Scheven BA; Burger EH; Kawilarang-de Haas EW; Wassenaar AM; Nijweide PJ
Lab Invest; 1985 Jul; 53(1):72-9. PubMed ID: 4010232
[TBL] [Abstract][Full Text] [Related]
7. Effects of transforming growth factor-beta on long-term human cord blood monocyte cultures.
Orcel P; Bielakoff J; De Vernejoul MC
J Cell Physiol; 1990 Feb; 142(2):293-8. PubMed ID: 1689319
[TBL] [Abstract][Full Text] [Related]
8. Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139].
Fenton AJ; Martin TJ; Nicholson GC
J Cell Physiol; 1993 Apr; 155(1):1-7. PubMed ID: 8468357
[TBL] [Abstract][Full Text] [Related]
9. S 12911-2 inhibits osteoclastic bone resorption in vitro.
Takahashi N; Sasaki T; Tsouderos Y; Suda T
J Bone Miner Res; 2003 Jun; 18(6):1082-7. PubMed ID: 12817762
[TBL] [Abstract][Full Text] [Related]
10. The effect of particle phagocytosis and metallic wear particles on osteoclast formation and bone resorption in vitro.
Neale SD; Haynes DR; Howie DW; Murray DW; Athanasou NA
J Arthroplasty; 2000 Aug; 15(5):654-62. PubMed ID: 10960005
[TBL] [Abstract][Full Text] [Related]
11. Calcitonin receptors as markers for osteoclastic differentiation: correlation between generation of bone-resorptive cells and cells that express calcitonin receptors in mouse bone marrow cultures.
Hattersley G; Chambers TJ
Endocrinology; 1989 Sep; 125(3):1606-12. PubMed ID: 2547591
[TBL] [Abstract][Full Text] [Related]
12. Carboxyl-terminal parathyroid hormone fragments stimulate osteoclast-like cell formation and osteoclastic activity.
Kaji H; Sugimoto T; Kanatani M; Miyauchi A; Kimura T; Sakakibara S; Fukase M; Chihara K
Endocrinology; 1994 Apr; 134(4):1897-904. PubMed ID: 8137758
[TBL] [Abstract][Full Text] [Related]
13. The cellular actions of interleukin-11 on bone resorption in vitro.
Hill PA; Tumber A; Papaioannou S; Meikle MC
Endocrinology; 1998 Apr; 139(4):1564-72. PubMed ID: 9528935
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.
de la Mata J; Uy HL; Guise TA; Story B; Boyce BF; Mundy GR; Roodman GD
J Clin Invest; 1995 Jun; 95(6):2846-52. PubMed ID: 7769125
[TBL] [Abstract][Full Text] [Related]
15. Indapamide, a thiazide-like diuretic, decreases bone resorption in vitro.
Lalande A; Roux S; Denne MA; Stanley ER; Schiavi P; Guez D; De Vernejoul MC
J Bone Miner Res; 2001 Feb; 16(2):361-70. PubMed ID: 11204436
[TBL] [Abstract][Full Text] [Related]
16. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors.
Chikazu D; Shindo M; Iwasaka T; Katagiri M; Manabe N; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859
[TBL] [Abstract][Full Text] [Related]
17. Macrophage colony stimulating factor increases bone resorption in dispersed osteoclast cultures by increasing osteoclast size.
Lees RL; Heersche JN
J Bone Miner Res; 1999 Jun; 14(6):937-45. PubMed ID: 10352102
[TBL] [Abstract][Full Text] [Related]
18. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
19. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
Roux S; Quinn J; Pichaud F; Orcel P; Chastre E; Jullienne A; De Vernejoul MC
J Cell Physiol; 1996 Sep; 168(3):489-98. PubMed ID: 8816903
[TBL] [Abstract][Full Text] [Related]
20. Colony-stimulating factors regulate the development of multinucleated osteoclasts from recently replicated cells in vitro.
Lorenzo JA; Sousa SL; Fonseca JM; Hock JM; Medlock ES
J Clin Invest; 1987 Jul; 80(1):160-4. PubMed ID: 3496361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]